Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve

被引:32
作者
Girolami, Elizabeth I. [1 ]
Bouhy, Delphine [1 ]
Haber, Michael [1 ]
Johnson, Howard [2 ]
David, Samuel [1 ]
机构
[1] McGill Univ, Ctr Hlth, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada
[2] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
SOCS; Macrophage; Cytokine; Inflammation; Wallerian degeneration; Peripheral nerve; CILIARY NEUROTROPHIC FACTOR; LEUKEMIA-INHIBITORY FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MYELIN-ASSOCIATED GLYCOPROTEIN; INTERLEUKIN-6; MESSENGER-RNA; CYTOKINE SIGNALING SOCS; SCHWANN-CELLS; MACROPHAGE INFILTRATION; FUNCTIONAL RECOVERY; RETROGRADE SIGNAL;
D O I
10.1016/j.expneurol.2009.06.018
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Pro-inflammatory chemokines and cytokines play an important role in Wallerian degeneration (WD) after peripheral nerve injury. These pro-inflammatory signals are "turned-off" in a timely manner to ensure that the inflammatory response in the injured nerve is limited. The factors that regulate the turning-off of the pro-inflammatory state are not fully understood. The suppressors of cytokine signaling (SOCS) proteins are potential candidates that could limit the inflammatory response by acting to regulate cytokine signaling at the intracellular level. In this work we show that the expression SOCS1 and SOCS3 proteins differ from each other during WD in the mouse sciatic nerve after cut/ligation and crush injuries. SOCS1 is mainly expressed by macrophages and its expression is inversely correlated with phosphorylation of JAK2 and STAT3 signaling proteins and the expression of pro-inflammatory cytokines IL-1 beta and TNF alpha. In addition, treatment of cut/ligated nerves, which express lower levels of SOCS1 as compared to crush injury, with a SOCS1 mimetic peptide leads to a decrease in macrophage numbers at 14 days post-injury and reduces IL-1 beta mRNA expression 1 day post-injury. In contrast, SOCS3 expression is restricted mainly to Schwann cells and is negatively correlated with the expression of IL-6 and LW. These data suggest that SOCS1 and SOCS3 may play different roles in WD and provide a better understanding of some of the potential regulatory mechanisms that may control inflammation and regeneration in the injured peripheral nerve. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:173 / 182
页数:10
相关论文
共 74 条
[1]
Suppressors of cytokine signalling (SOCS) in the immune system [J].
Alexander, WS .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :410-416
[2]
The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse [J].
Alexander, WS ;
Hilton, DJ .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :503-529
[3]
Requirement of myeloid cells for axon regeneration [J].
Barrette, Benoit ;
Hebert, Marc-Andre ;
Filali, Mohammed ;
Lafortune, Kathleen ;
Vallieres, Nicolas ;
Gowing, Genevieve ;
Julien, Jean-Pierre ;
Lacroix, Steve .
JOURNAL OF NEUROSCIENCE, 2008, 28 (38) :9363-9376
[4]
Be'eri M, 1998, EUR J NEUROSCI, V10, P2707
[5]
Bendszus M, 2003, J NEUROSCI, V23, P10892
[6]
Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation [J].
Berlato, C ;
Cassatella, MA ;
Kinjyo, I ;
Gatto, L ;
Yoshimura, A ;
Bazzoni, F .
JOURNAL OF IMMUNOLOGY, 2002, 168 (12) :6404-6411
[7]
Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia [J].
Biethahn, S ;
Alves, F ;
Wilde, S ;
Hiddemann, W ;
Spiekermann, K .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (05) :885-894
[8]
Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury [J].
Boivin, Audrey ;
Pineau, Isabelle ;
Barrette, Benoit ;
Filali, Mohammed ;
Vallieres, Nicolas ;
Rivest, Serge ;
Lacroix, Steve .
JOURNAL OF NEUROSCIENCE, 2007, 27 (46) :12565-12576
[9]
BOLIN LM, 1995, J NEUROCHEM, V64, P850
[10]
Bourde O, 1996, J NEUROIMMUNOL, V69, P135